Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Kollerits

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Atherosclerosis|July 25, 2013
The association of relative telomere length with symptomatic peripheral arterial disease: results from the CAVASIC studyJulia Raschenberger, Barbara Kollerits, Angelika Hammerer-Lercher, et al.
Clinical Chemistry|May 5, 2007
B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease StudyKatharina-Susanne Spanaus, Florian Kronenberg, Eberhard Ritz, et al.
Atherosclerosis|February 16, 2015
Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication - results from the CAVASIC StudyBarbara Rantner, Johannes Pohlhammer, Marietta Stadler, et al.
Atherosclerosis|December 3, 2014
High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC StudyJohannes Pohlhammer, Florian Kronenberg, Barbara Rantner, et al.
Atherosclerosis|October 13, 2012
Evaluation of gene-obesity interaction effects on cholesterol levels: a genetic predisposition score on HDL-cholesterol is modified by obesityClaudia Lamina, Lukas Forer, Sebastian Schönherr, et al.
Scientific Reports|April 4, 2017
The fate of patients with intermittent claudication in the 21st century revisited - results from the CAVASIC StudyBarbara Rantner, Barbara Kollerits, Johannes Pohlhammer, et al.
Journal of Medical Genetics|June 23, 2009
A common variant in the adiponutrin gene influences liver enzyme valuesBarbara Kollerits, Stefan Coassin, Stefan Kiechl, et al.
Experimental Gerontology|September 16, 2008
Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery diseaseArno Lingenhel, Barbara Kollerits, Johannes P Schwaiger, et al.
Clinical Chemistry|April 1, 2008
Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC studyBarbara Rantner, Barbara Kollerits, Marietta Anderwald-Stadler, et al.
Atherosclerosis|March 10, 2015
Serum concentrations of L-arginine and L-homoarginine in male patients with intermittent claudication: a cross-sectional and prospective investigation in the CAVASIC StudyLena Vogl, Johannes Pohlhammer, Andreas Meinitzer, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Atherosclerosis|July 25, 2013
The association of relative telomere length with symptomatic peripheral arterial disease: results from the CAVASIC studyJulia Raschenberger, Barbara Kollerits, Angelika Hammerer-Lercher, et al.
Clinical Chemistry|May 5, 2007
B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease StudyKatharina-Susanne Spanaus, Florian Kronenberg, Eberhard Ritz, et al.
Atherosclerosis|February 16, 2015
Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication - results from the CAVASIC StudyBarbara Rantner, Johannes Pohlhammer, Marietta Stadler, et al.
Atherosclerosis|December 3, 2014
High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC StudyJohannes Pohlhammer, Florian Kronenberg, Barbara Rantner, et al.
Atherosclerosis|October 13, 2012
Evaluation of gene-obesity interaction effects on cholesterol levels: a genetic predisposition score on HDL-cholesterol is modified by obesityClaudia Lamina, Lukas Forer, Sebastian Schönherr, et al.
Scientific Reports|April 4, 2017
The fate of patients with intermittent claudication in the 21st century revisited - results from the CAVASIC StudyBarbara Rantner, Barbara Kollerits, Johannes Pohlhammer, et al.
Journal of Medical Genetics|June 23, 2009
A common variant in the adiponutrin gene influences liver enzyme valuesBarbara Kollerits, Stefan Coassin, Stefan Kiechl, et al.
Experimental Gerontology|September 16, 2008
Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery diseaseArno Lingenhel, Barbara Kollerits, Johannes P Schwaiger, et al.
Clinical Chemistry|April 1, 2008
Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC studyBarbara Rantner, Barbara Kollerits, Marietta Anderwald-Stadler, et al.
Atherosclerosis|March 10, 2015
Serum concentrations of L-arginine and L-homoarginine in male patients with intermittent claudication: a cross-sectional and prospective investigation in the CAVASIC StudyLena Vogl, Johannes Pohlhammer, Andreas Meinitzer, et al.
Pageof 9